You just read:

Genomic Health Announces Presentation of New Oncotype DX® Studies Underscoring Unique Value of the Test in Early-Stage Breast Cancer at the 36th Annual CTRC-AACR San Antonio Breast Cancer Symposium

News provided by

Genomic Health, Inc.

Dec 14, 2013, 08:35 ET